KEMPHARM INC's ticker is and the CUSIP is 488445AB3. A total of 3 filers reported holding KEMPHARM INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $3,473,000 | -10.1% | 8,250,000 | 0.0% | 0.69% | +1.2% |
Q2 2019 | $3,865,000 | -6.1% | 8,250,000 | 0.0% | 0.68% | -10.2% |
Q1 2019 | $4,115,000 | +0.3% | 8,250,000 | 0.0% | 0.76% | +52.1% |
Q4 2018 | $4,104,000 | -17.5% | 8,250,000 | 0.0% | 0.50% | -25.5% |
Q3 2018 | $4,975,000 | -10.8% | 8,250,000 | 0.0% | 0.67% | -26.5% |
Q2 2018 | $5,577,000 | -8.8% | 8,250,000 | 0.0% | 0.91% | -29.1% |
Q1 2018 | $6,112,000 | +14.0% | 8,250,000 | 0.0% | 1.28% | -58.9% |
Q4 2017 | $5,363,000 | 0.0% | 8,250,000 | 0.0% | 3.11% | +82.0% |
Q3 2017 | $5,363,000 | -2.2% | 8,250,000 | 0.0% | 1.71% | -5.4% |
Q2 2017 | $5,486,000 | – | 8,250,000 | – | 1.81% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 75,000,000 | $57,250,000 | 1.98% |
DSC Advisors, L.P. | 8,250,000 | $6,112,000 | 1.28% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 3,000,000 | $2,065,000 | 0.16% |